Session Summary

The use of i2b2 for determining feasibility of clinical studies and clinical trials, focusing on the use of i2b2 in networks across the country, and novel approaches to allowing investigators to perform feasibility studies using i2b2-based client tools.

Presenters (4)

<html>
	<body>
		<h5 class="i2b2-event-presenter">Douglas MacFadden</h5>
			<p class="i2b2-event-presenter-position">Chief Informatics Officer</p>
			<p class="i2b2-event-presenter-company">Harvard Catalyst</p>
	</body>
</html>

<html>
	<body>
		<h5 class="i2b2-event-presenter">Nich Wattanasin, MS</h5>
			<p class="i2b2-event-presenter-position">Corporate Team Lead</p>
			<p class="i2b2-event-presenter-company">Partners HealthCare</p>
	</body>
</html>

<html>
	<body>
		<h5 class="i2b2-event-presenter">Jack London, PhD</h5>
<p class="i2b2-event-presenter-position">Research Professor Cancer Biology</p>
			<p class="i2b2-event-presenter-company">Thomas Jefferson University</p>
			<p class="i2b2-event-presenter-position">Director, Informatics Shared Resource</p>
			<p class="i2b2-event-presenter-company">Sidney Kimmel Cancer Center</p>
	</body>
</html>

<html>
	<body>
		<h5 class="i2b2-event-presenter">Kavi Wagholikar, PhD </h5>
			<p class="i2b2-event-presenter-position">Assistant in Computer Science</p>
			<p class="i2b2-event-presenter-company">Massachusetts General Hospital</p>
	</body>
</html>

Presentations (4)

Presentation 1: SHRINE Update

Review of all the new features added to the SHRINE Software

Presentation 2: Feasibility Studies Using SHRINE and i2b2

New features added to SHRINE and i2b2 Web Clients to help improve the workflow of identifying and extracting patient sets for clinical studies or trials.

Presentation 3: Using i2b2 Data to Determine Clinical Trial Feasibility in the TriNetX Network

Overview of cancer clinical trial accrual problem
TriNetX Clinical Research Network and Jefferson University's participation

Presentation 4: SMART on FHIR on i2b2

New FHIR Cell
Standardizing docker containers